Covid-19 roundup: J&J partners with UnitedHealth to hit the gas on vaccine trial enrollment; BioNTech CEO Ugur Sahin hits back at Trump while his vaccine gets cleared for China testing
The pharma is partnering with UnitedHealth Group to speed up enrollment in the hopes of reducing their trial time by half, according to a Bloomberg report. J&J head of global R&D Mathai Mammen told the news agency that they’ve only enrolled a few thousand patients in their 60,000-person trial, adding that the company’s initial goal of having data this year is now “a bit of a stretch.”
Keep reading Endpoints with a free subscription
Unlock this story instantly and join 109,800+ biopharma pros reading Endpoints daily — and it's free.